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Summary sentence: Our understanding of prions has progressed spectacularly since their discov-
ery four decades ago, yet some of the most important questions remain open. 
Paradigm shifts are drivers of scientific progress, yet the shifters of the paradigms often experi-
ence scorn rather than immediate applause. That was the fate of Stanley Prusiner’s 1982 paper 
claiming - to the initial amusement of his colleagues - that scrapie, a degenerative disease that af-
fects the central nervous system of sheep, is caused by “proteinaceous infectious particles”, which 
he termed prions (1). Prusiner’s intuition, which earned him the 1997 Nobel Prize, is influencing 
our approach to an ever-expanding variety of seemingly unrelated diseases and physiological pro-
cesses, and its implications reverberate to the present day.  
The two decades preceding Prusiner’s paper had witnessed the immense success of molecular bi-
ology, including the cracking of the genetic code, the elucidation of DNA replication, transcription 
and translation, and the cloning of genes. These discoveries prompted Francis Crick to conceptual-
ize the “Central Dogma”: information flows unidirectionally from DNA to proteins. But while reli-
gious dogmas may be eternal, the shelf life of scientific dogmas is inevitably limited. Prusiner pos-
tulated that prions carry on their replicative cycle without the participation of nucleic acids. This 
hypothesis, reminiscent of Griffith’s 1967 suggestion of the existence of self-replicating proteins 
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(2), had the potential to explain the prodigious resistance of the scrapie agent to DNA-damaging 
radiation. Carleton Gajdusek, who won a Nobel Prize for showing that Kuru was a human disease 
transmitted by cannibalism in Papua New Guinea, had proposed in 1959 that the neurodegenera-
tive disorders Kuru, scrapie and Creutzfeldt-Jakob disease (CJD) are caused by “slow viruses”. In-
deed, prions behave similarly to neurotropic viruses in many surprising ways, including the coloni-
zation of extraneural organs followed by neuroinvasion of the brain via peripheral nerves (3). Yet 
Prusiner purified the agent and found it to be smaller than a virus: no informational nucleic acid 
would fit into it. Over time, the group of prion diseases grew to include other human (Fatal Famil-
ial Insomnia) and animal disorders (Mad Cow Disease and Chronic Wasting Disease), but no causa-
tive virus has been identified and their prion etiology is now well accepted.   
But prions did not contradict Crick’s Central Dogma after all. Charles Weissmann, refusing to be-
lieve that a protein could exist without its respective gene, discovered in hamsters the gene en-
coding the cellular prion protein (PrPC), whose misfolding yields tightly-packed aggregates called 
PrPSc. It is generally believed that prion replication occurs when coalesced PrPSc is broken down 
into smaller species. Those species then accrue further PrPSc in a process akin to the growth of 
crystals – and eventually break again, perpetuating their replicative cycle. Infectious prion seeds 
then move to neighboring cells and wreak havoc in the central nervous system by inducing vacuo-
lation (“spongiosis”) within neurons.  
Does this mean that PrPSc is the prion? Weissmann’s discovery in 1993 that Prnp-ablated mice are 
resistant to scrapie (4) was designed to disprove the protein-only hypothesis, and failed to do so - 
but it fell short of proving it. If PrPC were the receptor of an imaginary “scrapie virus”, its ablation 
may also render mice resistant to scrapie. More direct evidence for Prusiner’s ideas emerged in 
2001 from Claudio Soto’s landmark experiment: repeated cycles of PrPSc fragmentation, when fol-
lowed by addition of PrPC and aggregate regeneration, can multiply prions ad libitum (5). These 
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findings strengthen the hypothesis that transfer of structural information can occur horizontally 
between proteins. 
More recently the prion concept has been applied, sometimes overenthusiastically, to virtually all 
diseases characterized by progressive deposition of aggregated proteins in the central nervous 
system, whether infectious or not – and even to physiological processes such as memory for-
mation (6). α-synuclein aggregates can self-propagate in the brains of Parkinson’s patients (7), in 
cultured cells and in mice (8). This implies that synuclein is a de facto prion, and that its handling 
demands high biosafety standards. Similar arguments were made for tau and Aβ aggregates, the 
major hallmarks of Alzheimer’s disease (9). However, prions caused many epidemics, whereas in-
fectiousness has not been conclusively demonstrated for other protein aggregates, and specifically 
not via oral transmission  Protein aggregates that were not shown to be serially transmissible 
across multiple generations of hosts are better regarded as “prionoids”, even if they share molec-
ular mechanisms of amplification with bona fide prions in vitro.  
As predicted by Prusiner in the closing lines of his paper, the “prion revolution” boosted research 
in the field of neurodegeneration by providing an intellectual framework that might explain many 
aspects of Alzheimer’s, Parkinson’s and many other diseases featuring protein aggregates. While 
cellular PrPC is now known to be crucial for the maintenance of peripheral myelin (10), our under-
standing of prions has essentially stagnated for more than a decade, and may now be lagging be-
hind that of prionoids.  What do we really know about prions, after almost 40 years from Prus-
iner’s discovery? 
One crucial obstacle to advancing prion research is the lack of high-resolution structures of PrPSc 
due to its insolubility, its non-crystalline aggregational state, and the persistent difficulties in pre-
paring high-purity infectious material de novo from recombinant protein (11). This raises the possi-
bility that infectious aggregates may constitute a sparsely-populated conformational variant 
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within such preparations. If so, most material aggregated in vitro may be non-infectious, and may 
not be informative of the structure of the prion and of its replicative mechanism.  
Among all the models that have been proposed so far, the most plausible suggests that the prion 
consists of fibrils arranged as four-rung β-solenoids (12) stacked either head-to-tail or head-to-
head. Cryo-electron microscopy of purified glycosylphosphatidylinositol (GPI)-anchorless prion fi-
brils (13) supports this model, thus providing the first high-magnification images of infectious pri-
ons, albeit the resolution does not suffice to determine the precise arrangement of the monomers 
within the fibrils. These structures are quite different from those of tau, α−synuclein and Aβ, and 
differ also from recombinant PrP fibrils – all of which are arranged in long fibers with no cavity. 
Hence PrPSc has unique structural characteristics, but it is unknown whether and how these peculi-
arities relate to  their frightening infectivity.  
The link between the generation of PrP aggregates and their neurotoxicity is also unclear. A large 
body of evidence (14) indicates that PrPC is necessary for toxicity, perhaps because extracellular 
PrPSc oligomers dock to PrPC on cell surfaces. Another aspect unique to prion infections pertains to 
the peculiar morphology of the damage that it wreaks on the brain. Of all aggregation-prone pro-
teins, prions are the only ones that cause extensive intraneuronal vacuolation (spongiosis), whose 
severity increases during disease progression. This phenomenon is as much intriguing as it is mys-
terious. To date, almost nothing is known about the cellular and molecular pathology underlying 
vacuole formation;  yet its ubiquity in all known prion diseases suggests that they are a prime 
driver of toxicity – and therefore also a  target for therapeutic interventions.  
High-resolution 3D structures of prions are also required to solve the long-standing question of 
prion strains, which share the same PrP sequence and yet cause distinct diseases (e.g. “hyper” and 
“drowsy” phenotypes in minks)  whose traits are maintained over successive rounds of infection. 
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Viral strains are defined by specific polymorphisms in their respective genomes, and their exist-
ence in prion diseases was long thought to be incontrovertible evidence for the involvement of nu-
cleic acids. However, after four decades of failed attempts to isolate any scrapie-specific genomes, 
strains are now thought to be caused by different PrPSc conformations which can be distinguished 
with conformer-sensitive fluorescent polythiophenes.  
Embarrassingly for the prion field, no definitive structural evidence for these presumptions has 
come forward, and the “strainness” of bona fide infectious prions is still diagnosed using imperfect 
surrogate biomarkers such as differential resistance to disaggregation and proteolysis. By contrast, 
conformational heterogeneity was reported to correlate with distinct clinical phenotypes in some 
prionoid pathologies - although the stability of different conformations in serial transmission ex-
periments is not yet fully established.  
But how stable are prion strains across generations? RNA viruses achieve maximal fitness by creat-
ing quasispecies, clouds of variants in precarious equilibrium between adaptive mutagenesis and 
error catastrophe. Surprisingly, prions can also engender quasispecies whose monoclonal constitu-
ents can be isolated from cultured cells by applying various kinds of selective pressure (15). The 
structural mechanisms underlying this phenomenon are unknown and may involve conformational 
selection of distinct PrPSc species. The conformational selection model predicates the coexistence 
of multiple conformers within a single infected organism, some of which may replicate more effi-
ciently in their host under certain environmental circumstances. The incubation time of prion in-
fections can vary immensely between different strains, and the delay in the onset of the pathology 
might reflect the time needed for such selection to occur. 
PrPSc conformer heterogeneity may also underlie the barriers that control interspecies prion trans-
mission, whose strength is variable and depends both on host factors and on prion strains. While 
prion propagation from cows to humans results in variant Creutzfeldt-Jakob disease, sheep prions 
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appear to be largely innocuous to humans. This species barrier relies both on the structural diver-
sity of the PrPSc contained in the inoculum and the PrPC of the host, which cannot always interact 
with the misfolded conformer efficiently.  
The ideas promulgated by Prusiner have undergone a remarkable metamorphosis. Templated nu-
cleation of protein aggregates is now known to underlie not only diseases but also many physio-
logical processes – some of which bear little resemblance to the original set of diseases that at-
tracted Prusiner’s attention. Remarkably, the structural predictions of the prion model were veri-
fied for several prionoids, but not for prions. As such, many of the questions raised by Prusiner in 
1982 – prion structure, mechanism of replication, drivers of toxicity – are still open. Based on his-
torical evidence, addressing these questions in the prion arena may, once again, provide answers 
that will also apply to more prevalent diseases.  
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Figure  
Three centuries of prion science (A) Time line of prion-related discoveries. (B) Micrograph of a 
Creutzfeldt-Jakob brain with numerous vacuoles (spongiosis); (C) A polythiophene complexed with 
the yeast prion Het-S; (D) A four-rung β-solenoid structure modelling the architecture of prions.  
 
1732 – Scrapie reported in sheep 
1898 – Neuronal vacuolation recognized as a feature of scrapie  
1936 – Scrapie transmissibility recognized 
1959 – Similarities between scrapie, CJD and kuru reported 
1982 – Prusiner isolates the scrapie agent and names it “prion”  
1993 – Mice without the Prnp gene are resistant to prions 
1996 – PrPc is essential for prion neurotoxicity 
2001 – Protein misfolding cyclic amplification 
2007 – Spectral discrimination of prion strains  
2016 – PrPc controls myelin homeostasis 
2019 – A plausible model of prion structure  
